Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on neglected epilepsy drug, promotes FDA manage

.Our company currently recognize that Takeda is actually intending to locate a path to the FDA for e...

VBI Vaccines files for personal bankruptcy, seeks property purchase

.Immunology biotech VBI Vaccinations is diverting dangerously near to the climax, with plans to decl...

Celldex anti-cKIT antitoxin reduce hives in yet another stage 2 research study

.It is actually not easy to muscular tissue in on a space as competitive as immunology, but Celldex ...

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Rehabs and also a preclinical invulnera...

Ventyx's last hope for inflamed med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's illness medicine carried out certainly not help people accomplish remis...

Cognition's stage 2 radiate records blemish Alzheimer's possibility

.Cognition Rehabs' period 2 luster test has taken a few of the luster off the Alzheimer's disease dr...

BMS centers bispecific months after filing to operate period 3 trial

.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that looked after Mirati Therapeutics' $ 5.8 billion purchase to Bristol...

Asarina to close after efforts to partner Tourette's drug stop working

.After reaching out to more than 200 companies to companion a Tourette disorder therapy that showed ...